Tokyo Tape
Sign in
← Cytori Cell Research Institute

Quarterly report · Q3

3750.TEDINET S100Q6BK
Period2022-04-01 → 2022-12-31
Filed2023-02-10
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 34
MetricValuePeriodScopeSource row
Revenue¥1.7bn2022-04-01 → 2022-12-31Cons.Net sales
Revenue¥1.3bn2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Revenue¥1.0bn2021-04-01 → 2021-12-31Cons.Net sales
Operating income−¥516m2022-04-01 → 2022-12-31Cons.Operating income
Operating income−¥296m2021-04-01 → 2021-12-31Cons.Operating income
Ordinary income−¥602m2022-04-01 → 2022-12-31Cons.Ordinary income
Ordinary income−¥418m2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income−¥271m2021-04-01 → 2021-12-31Cons.Ordinary income
Profit before tax−¥710m2022-04-01 → 2022-12-31Cons.Income before income taxes
Profit before tax¥41m2021-04-01 → 2021-12-31Cons.Income before income taxes
Net income (owners)−¥723m2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)−¥78m2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥61m2021-04-01 → 2021-12-31Cons.Profit loss attributable to owners of parent
Net income−¥723m2022-04-01 → 2022-12-31Cons.Profit loss
Net income¥62m2021-04-01 → 2021-12-31Cons.Profit loss
Total assets¥14.1bnat 2022-12-31Cons.Assets
Total assets¥16.0bnat 2022-03-31Cons.Assets
Total assets¥16.0bnat 2021-12-31Cons.Total assets (5-year summary)
Total liabilities¥11.1bnat 2022-12-31Cons.Liabilities
Total liabilities¥12.3bnat 2022-03-31Cons.Liabilities
Net assets / equity¥3.0bnat 2022-12-31Cons.Net assets
Net assets / equity¥3.7bnat 2022-03-31Cons.Net assets
Net assets / equity¥3.8bnat 2021-12-31Cons.Net assets (5-year summary)
Cash and deposits¥776mat 2022-12-31Cons.Cash and deposits
Cash and deposits¥852mat 2022-03-31Cons.Cash and deposits
EPS (basic)¥-80.952022-04-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-18.092022-10-01 → 2022-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-8.792021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥6.972021-04-01 → 2021-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥10.82021-10-01 → 2021-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥6.812021-04-01 → 2021-12-31Cons.Diluted earnings per share (5-year summary)
Equity ratio19.7%at 2022-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio21.9%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio22.4%at 2021-12-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 20
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-04-01 → 2022-12-31−¥116m
jpcrp040300-q3r_E05443-000Medical Asset Managemetreportable segmentrevenue2022-04-01 → 2022-12-31¥128m
jpcrp040300-q3r_E05443-000Medical Asset Managemetreportable segmentrevenue external2022-04-01 → 2022-12-31¥128m
jpcrp040300-q3r_E05443-000Medical Asset Managemetreportable segmentsegment profit2022-04-01 → 2022-12-31−¥224m
jpcrp040300-q3r_E05443-000Real Asset Managementreportable segmentrevenue2022-04-01 → 2022-12-31¥1.5bn
jpcrp040300-q3r_E05443-000Real Asset Managementreportable segmentrevenue external2022-04-01 → 2022-12-31¥1.5bn
jpcrp040300-q3r_E05443-000Real Asset Managementreportable segmentsegment profit2022-04-01 → 2022-12-31−¥176m
—segment totalrevenue2022-04-01 → 2022-12-31¥1.7bn
—segment totalrevenue external2022-04-01 → 2022-12-31¥1.7bn
—segment totalsegment profit2022-04-01 → 2022-12-31−¥400m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2021-04-01 → 2021-12-31−¥110m
jpcrp040300-q3r_E05443-000Medical Asset Managemetreportable segmentrevenue2021-04-01 → 2021-12-31¥170m
jpcrp040300-q3r_E05443-000Medical Asset Managemetreportable segmentrevenue external2021-04-01 → 2021-12-31¥170m
jpcrp040300-q3r_E05443-000Medical Asset Managemetreportable segmentsegment profit2021-04-01 → 2021-12-31−¥133m
jpcrp040300-q3r_E05443-000Real Asset Managementreportable segmentrevenue2021-04-01 → 2021-12-31¥870m
jpcrp040300-q3r_E05443-000Real Asset Managementreportable segmentrevenue external2021-04-01 → 2021-12-31¥870m
jpcrp040300-q3r_E05443-000Real Asset Managementreportable segmentsegment profit2021-04-01 → 2021-12-31−¥53m
—segment totalrevenue2021-04-01 → 2021-12-31¥1.0bn
—segment totalrevenue external2021-04-01 → 2021-12-31¥1.0bn
—segment totalsegment profit2021-04-01 → 2021-12-31−¥186m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 323
ItemContextValueUnit
Ordinary incomePrior1YTDDuration-270974000JPY
Ordinary incomeCurrentYTDDuration-601827000JPY
Gain on sales of investment securities noiPrior1YTDDuration85510000JPY
Gain on sales of investment securities noiCurrentYTDDuration－JPY
Gain on negative goodwill eiPrior1YTDDuration214377000JPY
Gain on negative goodwill eiCurrentYTDDuration－JPY
Other eiPrior1YTDDuration－JPY
Other eiCurrentYTDDuration0JPY
Extraordinary incomePrior1YTDDuration299888000JPY
Extraordinary incomeCurrentYTDDuration0JPY
Loss on sale of investments in capital of subsidiaries and associates elPrior1YTDDuration－JPY
Loss on sale of investments in capital of subsidiaries and associates elCurrentYTDDuration107628000JPY
Impairment loss elPrior1YTDDuration－JPY
Impairment loss elCurrentYTDDuration6295000JPY
Other elPrior1YTDDuration－JPY
Other elCurrentYTDDuration2374000JPY
Extraordinary lossPrior1YTDDuration－JPY
Extraordinary lossCurrentYTDDuration116298000JPY
Income before dividends distribution from silent partnership income taxesPrior1YTDDuration28913000JPY
Income before dividends distribution from silent partnership income taxesCurrentYTDDuration-718125000JPY
Dividends distribution from silent partnershipPrior1YTDDuration-12529000JPY
Dividends distribution from silent partnershipCurrentYTDDuration-8093000JPY
Income before income taxesPrior1YTDDuration41443000JPY
Income before income taxesCurrentYTDDuration-710032000JPY
Income taxes currentPrior1YTDDuration1976000JPY
Income taxes currentCurrentYTDDuration1451000JPY
Income taxes deferredPrior1YTDDuration-22229000JPY
Income taxes deferredCurrentYTDDuration11218000JPY
Income taxesPrior1YTDDuration-20252000JPY
Income taxesCurrentYTDDuration12670000JPY
Profit lossPrior1YTDDuration61695000JPY
Profit lossCurrentYTDDuration-722703000JPY
Profit loss attributable to non controlling interestsPrior1YTDDuration411000JPY
Profit loss attributable to non controlling interestsCurrentYTDDuration97000JPY
Profit loss attributable to owners of parentPrior1YTDDuration61284000JPY
Profit loss attributable to owners of parentCurrentYTDDuration-722800000JPY
Profit lossPrior1YTDDuration61695000JPY
Profit lossCurrentYTDDuration-722703000JPY
Valuation difference on available for sale securities net of tax ociPrior1YTDDuration62000JPY
Valuation difference on available for sale securities net of tax ociCurrentYTDDuration35000JPY
Other comprehensive incomePrior1YTDDuration62000JPY
Other comprehensive incomeCurrentYTDDuration35000JPY
Comprehensive incomePrior1YTDDuration61758000JPY
Comprehensive incomeCurrentYTDDuration-722668000JPY
Comprehensive income attributable to owners of the parentPrior1YTDDuration61347000JPY
Comprehensive income attributable to owners of the parentCurrentYTDDuration-722765000JPY
Comprehensive income attributable to non controlling interestsPrior1YTDDuration411000JPY
Comprehensive income attributable to non controlling interestsCurrentYTDDuration97000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q3r_E05443-000MedicalAssetManagemetReportableSegmentsMember169736000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q3r_E05443-000RealAssetManagementReportableSegmentsMember869983000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-03-31pass rounding
balance sheet identityconsolidated 2022-12-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2021-04-01/2021-12-31pass
statement vs summary · revenueconsolidated 2022-04-01/2022-12-31pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-12-31pass